Hypertension
📧 Sign up to get email alerts when something new happens for Hypertension.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2019-07-01FDA Approved: CHLORTHALIDONE — Original Application (Amneal Pharmaceuticals LLC)
The FDA approved Amneal Pharmaceuticals LLC's original application for chlorthalidone, a thiazide-like diuretic used to treat hypertension a…
-
CLINICAL_TRIALS trial_result · 2019-06-28Clinical Trial Update: Northwestern University and Access Community Health Network Medication Education Study [NA]
Clinical trial update for a medication education study exploring hypertension management by Northwestern University and Access Community Hea…
-
CLINICAL_TRIALS trial_result · 2019-06-25Clinical Trial Update: Nebivolol and Endothelial Regulation of Fibrinolysis (NERF) [Phase 4]
Phase 4 trial update for Nebivolol focusing on endothelial regulation of fibrinolysis; study completed with results posted in 2019.
-
FDA approval · 2019-06-24FDA Approved: LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE — Supplemental Application (Unichem Pharmaceuticals (USA), Inc.)
FDA approved a supplemental application for Losartan Potassium and Hydrochlorothiazide from Unichem Pharmaceuticals (USA), Inc., updating th…
-
FDA approval · 2019-06-24FDA Approved: LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE — Supplemental Application (Macleods Pharmaceuticals Limited)
The FDA approved a supplemental application for a generic Losartan Potassium and Hydrochlorothiazide product from Macleods Pharmaceuticals L…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2019-06-24FDA Approved: LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE — Supplemental Application (NorthStar Rx LLC)
FDA approved a supplemental application for NorthStar Rx LLC to market losartan potassium and hydrochlorothiazide, a fixed-dose combination …
-
CLINICAL_TRIALS trial_result · 2019-06-21Clinical Trial Update: Effectiveness of Avapro in Obese Normotensive/Hypertensive African Americans [Phase 2]
Phase 2 trial update evaluating the effectiveness of Avapro in obese normotensive and hypertensive African Americans.
-
CLINICAL_TRIALS trial_result · 2019-06-20Clinical Trial Update: Effectiveness of Prazosin on the Urinary Sodium Excretion Response to Mental Stress [Phase 2]
Phase 2 trial update assessing prazosin's effect on urinary sodium excretion in response to mental stress in hypertension, completed.
-
CLINICAL_TRIALS trial_result · 2019-06-20Clinical Trial Update: Valsartan Versus Amlodipine Effect on Left Ventricular Multidirectional Deformation and Adipocytokines Level [Phase 4]
Phase 4 trial comparing valsartan and amlodipine on left ventricular deformation and adipocytokines in hypertension patients has completed.
-
CLINICAL_TRIALS trial_result · 2019-06-20Clinical Trial Update: Effects of an Immunosuppressant Mycophenolate Mofetil or MMF on the Urinary Sodium Excretion Response to Mental Stress [Phase 1, Phase 2]
Clinical trial exploring the effects of immunosuppressant mycophenolate mofetil (MMF) on urinary sodium excretion response to mental stress …
-
FDA approval · 2019-06-14FDA Approved: DILTIAZEM HYDROCHLORIDE — Original Application (Ingenus Pharmaceuticals, LLC)
The FDA approved Ingenus Pharmaceuticals' generic diltiazem hydrochloride via an original ANDA submission.
-
CLINICAL_TRIALS trial_result · 2019-06-13Clinical Trial Update: Conditioned Pharmacotherapeutic Effects in Hypertension [Phase 4]
Phase 4 trial update on conditioned pharmacotherapeutic effects in hypertension completed with posted results.
-
FDA approval · 2019-06-12FDA Approved: DIOVAN HCT — Supplemental Application (Novartis Pharmaceuticals Corporation)
FDA approved a supplemental application for Diovan HCT (valsartan/hydrochlorothiazide) submitted by Novartis Pharmaceuticals Corporation.
-
FDA approval · 2019-06-12FDA Approved: EXFORGE HCT — Supplemental Application (Novartis Pharmaceuticals Corporation)
FDA approved a supplemental application for EXFORGE HCT (amlodipine, valsartan, and hydrochlorothiazide) from Novartis Pharmaceuticals Corpo…
-
FDA approval · 2019-06-12FDA Approved: DIOVAN — Supplemental Application (Novartis Pharmaceuticals Corporation)
FDA approved a supplemental application for DIOVAN (valsartan) submitted by Novartis Pharmaceuticals Corporation.
-
FDA approval · 2019-06-12FDA Approved: EXFORGE — Supplemental Application (Novartis Pharmaceuticals Corporation)
FDA approved a supplemental application for EXFORGE (amlodipine besylate and valsartan) from Novartis Pharmaceuticals Corporation.
-
CLINICAL_TRIALS trial_result · 2019-06-06Clinical Trial Update: Tele-Pharmacy Intervention to Improve Treatment Adherence [NA]
A completed clinical trial investigating a tele-pharmacy intervention to improve treatment adherence in patients with hyperlipidemia and dia…
-
CLINICAL_TRIALS trial_result · 2019-06-03Clinical Trial Update: Azilsartan/Amlodipine Combination Tablets LD & HD Specified Drug-use Survey "Long-term Use Survey"
Clinical trial update reporting long-term use survey results for azilsartan/amlodipine combination tablets in hypertension; results posted a…
-
CLINICAL_TRIALS trial_result · 2019-06-03Clinical Trial Update: Dialysate Sodium Lowering Trial [Phase 2]
Phase 2 trial evaluating lower dialysate sodium in hemodialysis patients has completed.
-
CLINICAL_TRIALS trial_result · 2019-06-03Clinical Trial Update: China Protection Trial of Glucose Metabolism by Pitavastatin in Patients With Prediabetes and Hypertension [Phase 4]
Phase 4 trial investigating the effects of pitavastatin on glucose metabolism in adults with prediabetes and hypertension.
-
CLINICAL_TRIALS trial_result · 2019-06-03Clinical Trial Update: Impact of Consumption of Beta-glucans on the Intestinal Microbiota and Glucose and Lipid Metabolism [NA]
A completed clinical trial assessed the impact of beta-glucan consumption on the intestinal microbiota and glucose and lipid metabolism in i…
-
CLINICAL_TRIALS trial_result · 2019-05-22Clinical Trial Update: Tissue Sodium in Pre-hypertensive Patients [Phase 2]
Phase 2 clinical trial on tissue sodium in pre-hypertensive patients has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2019-05-21Clinical Trial Update: The Use of Magnesium to Improve Blood Pressure, Cholesterol, and Glucose Control [Phase 4]
A Phase 4 clinical trial evaluated magnesium's effect on blood pressure, cholesterol, and glucose control in patients with cardiovascular ri…
-
CLINICAL_TRIALS trial_result · 2019-05-21Clinical Trial Update: Study to Evaluate Symptoms in Patients Treated With Nebivolol or Metoprolol Extended-release (ER) for Hypertension [Phase 3]
Phase 3 trial update comparing nebivolol and metoprolol extended-release for hypertension; study terminated with results posted.
-
FDA approval · 2019-05-19FDA Approved: BENAZEPRIL HYDROCHLORIDE — Supplemental Application (Amneal Pharmaceuticals of New York LLC)
The FDA approved a supplemental application for benazepril hydrochloride submitted by Amneal Pharmaceuticals of New York LLC, indicating an …